For nearly 20 years, CutisPharma's singular focus has been to address the needs of patients who are unable to take capsules or tablets, such as children and the elderly, for whom no therapy is commercially available.
Indu A. Muni, Ph.D.Founder and Chairman of the Board
Dr. Muni is currently the CEO of ROMEG Therapeutics, LLC, www.romegrx.com. Dr. Muni founded CutisPharma in 1998 and served as the Company’s CEO until May 2015. Dr. Muni brings over 40 years of experience in the pharmaceutical industry, with a deep background in pharmacy and toxicology. Prior to founding CutisPharma, Dr. Muni served as the CEO of DynaGen, Inc., a publicly-held biotechnology company. Prior to DynaGen, Dr. Muni served in numerous senior level positions in the pharmaceutical, chemical and toxicology testing industries including BioAssay Systems, Inc., Miles Laboratories, and JT Baker. Dr. Muni has a Ph.D. in Biochemistry/Pharmacology from the University of Mississippi.